Medtronic Spinal and Biologics Clinical Trials
Sponsors / Medtronic Spinal and Biologics
ClinicalTrials.gov lists 50 trials for which Medtronic Spinal and Biologics is named as lead sponsor. The portfolio currently includes 1 recruiting studies, 2 active non-recruiting studies, and 35 completed studies. 11 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, regulatory actions. Cumulative planned enrollment across all listed trials is 9,256 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
50
Total Trials
1
Recruiting
2
Other Active
35
Completed
11
Terminated / Withdrawn
9,256
Total Enrollment
Termination reasons: Other36% · Recruitment27% · Regulatory9% · Efficacy9% · Business9% · Safety9%
Recent Terminations
- Cervical Degenerative Disc Disease"Study terminated prematurely as agreed by the FDA. The FDA were satisfied that no further data was required, despite the total number of patients who completed the study in full not being the agreed upon number."
- Deformity of Spine"Delay in enrollment as compared to plan (impacted by COVID-19 pandemic) and availability of data from other data sources to support the products in scope."
- Lumbar Degenerative Disc Disease"Business decision, no safety concerns"
- NCT02657421 Stopped May 2018Degenerative Disc Disease"Business Decision"
- Lumbar Spine Degeneration"Due to study design challenges including DMC enrollment suspension as required by the protocol stopping rules and recommended changes to the surgical technique"
- Tibial Delayed Healing"Difficulty in patient recruitment"
- Degenerative Lumbar Spinal Stenosis"slow patient recruitment"
- Degenerative Cervical Disc Disease
- Degenerative Disc Disease
- Degenerative Disc Disease
Active Trials (2 total)
- NCT04073563
- NCT03118505
- NCT05299762